U.S. and Canadian stocks tumbled as dismal ISM manufacturing index numbers added to uncertainty caused by signs of weakness in emerging markets such as Turkey and China.
Everything you could ever want to know about biotech, biomed and bio investments up north.
Existing board has so far refused to yield to pressure for a meeting with shareholders who are unhap
since, more or less, January One, deadline has now passed for that. Hoping we can hold onto that increment until CEO "wows" us with...
Buying opportunities could be just around the corner. Low $ 140's looking at the chart . I am watching closely here now. If the low $...
an upside of US$29 to a target of US$170.00.
same datewe get an upgrade, State-side, for a US$25 price uplift (don't recall the source)
Donville's picks are spectacular. Last year I bought Badger, Paladin, Valeant and Constellation. They're all up huge amounts.